cabergoline
chemical compound
Facts
14 properties- Instance of
- type of chemical entity
- Subclass of
- ergoline alkaloid
- Has use
- medication
- Canonical SMILES
- CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
- Chemical formula
- C₂₆H₃₇N₅O₂
- Defined daily dose
- 3 mg, 0.5 mg
- Isomeric SMILES
- CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
- Mass
- 451.294725 Da
- Medical condition treated
- Parkinson's disease, hyperprolactinemia, benign neoplasm of pituitary gland, prolactin producing pituitary tumor, prolactinoma
- Physically interacts with
- 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 1B, 5-hydroxytryptamine receptor 1D, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C, Adrenoceptor alpha 1A, Adrenoceptor alpha 2A, Adrenoceptor alpha 2B, Adrenoceptor alpha 2C, Dopamine receptor D1, Dopamine receptor D2, Dopamine receptor D3, Dopamine receptor D4, Dopamine receptor D5
- Pregnancy category
- US pregnancy category B
- Significant drug interaction
- levomepromazine, zuclopenthixol, (Z)-flupentixol, (RS)-sulpiride, droperidol, fluphenazine, haloperidol, chlorpromazine
- Subject has role
- dopamine agonist, antiparkinson, antineoplastic
- World Health Organisation international non-proprietary name
- cabergoline
🏷️ Also known as
en Cabergolinum
en Caberlin®
en 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
en 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
en 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
en 1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
en 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea
en 1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea
en (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide
en (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide
en (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide
en (8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide
en Cabaser®
en Cabergolina
en cabergoline
en Cabergoline
ar كابرجولين
de Cabergolin
es Dostinex
fa کابرگولین
🔖 Identifiers · 36
- OpenAlex ID
- C2779832395
- CAS Registry Number
- 81409-90-7
- ChEBI ID
- 3286
- ChEMBL ID
- CHEMBL1201087
- ChemSpider ID
- 49452
- DSSTOX compound identifier
- DTXCID502719
- DSSTox substance ID
- DTXSID6022719
- DeCS ID
- 57653
- DrugBank ID
- DB00248
- DrugCentral ID
- 460
- EC number
- 627-031-8
Show all 36 identifiers +24
- ECHA Substance Infocard ID
- 100.155.380
- Electronic Essential Medicines List medicine ID
- 593
- Freebase ID
- /m/051b_1
- Guide to Pharmacology Ligand ID
- 37
- Human Metabolome Database ID
- HMDB0014393
- InChIKey
- KORNTPPJEAJQIU-KJXAQDMKSA-N
- MeSH descriptor ID
- D000077465
- MeSH tree code
- D03.132.327.287.131, D03.633.400.439.197
- MedlinePlus drug identifier
- a612020
- Microsoft Academic ID (discontinued)
- 2779832395
- NDF-RT ID
- N0000148483
- Probes And Drugs ID
- PD010146
- PubChem CID
- 54746
- Quora topic ID
- Cabergoline
- Reaxys registry number
- 6020775
- RxNorm CUI
- 47579
- Römpp online ID
- RD-03-00015
- SureChEMBL ID
- 42292
- UMLS CUI
- C0107994
- UNII
- LL60K9J05T
- UniChem compound ID
- 610539
- WikiProjectMed ID
- Cabergoline
🔗 Connections
Significant drug interaction 7
← Significant drug interaction 7
Physically interacts with 4
← Physically interacts with 4
Medical condition treated 3
Subject has role 3
← Drug or therapy used for treatment 3
Has use 1
Press Enter · cited answer in seconds
0 sources
Summary
cabergoline is a type of chemical entity[1].
Key Facts
- Physically interacts with: 5-hydroxytryptamine receptor 1A[2], 5-hydroxytryptamine receptor 1B[3], 5-hydroxytryptamine receptor 1D[4], 5-hydroxytryptamine receptor 2A[5], 5-hydroxytryptamine receptor 2B[6], 5-hydroxytryptamine receptor 2C[7], Adrenoceptor alpha 1A[8], Adrenoceptor alpha 2A[9], Adrenoceptor alpha 2B[10], Adrenoceptor alpha 2C[11], Dopamine receptor D1[12], Dopamine receptor D2[13], Dopamine receptor D3[14], Dopamine receptor D4[15]
- Canonical SMILES: CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C[16]
- Chemical formula: C₂₆H₃₇N₅O₂[17]
- Subclass of: ergoline alkaloid[18]
- Has use: medication[19]
- Significant drug interaction: levomepromazine[20], zuclopenthixol[21], (Z)-flupentixol[22], (RS)-sulpiride[23], droperidol[24], fluphenazine[25], haloperidol[26], chlorpromazine[27]
- Isomeric SMILES: CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2C@@HN(C1)CC=CC@@HN(C1)CC=C">[28]
- Mass: 451.294725 dalton[29]
- Medical condition treated: Parkinson's disease[30], hyperprolactinemia[31], benign neoplasm of pituitary gland[32], prolactin producing pituitary tumor[33], prolactinoma[34]
- World Health Organisation international non-proprietary name: cabergoline[35]
- Subject has role: dopamine agonist[36], antiparkinson[37], antineoplastic[38]
- Pregnancy category: US pregnancy category B[39]
- Defined daily dose: 3 milligram[40], 0.5 milligram[41]